Sudbury Vertigo Risk Score
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk-4–4
- Moderate Risk5–8
- High Risk9–17
The Sudbury Vertigo Risk Score calculates quantifying neurological deficit severity, stroke volume, and reperfusion therapy eligibility. Key inputs include male sex. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Identifies vertigo patients at higher risk for serious central diagnosis including stroke, TIA, vertebral artery dissection, or brain tumor in the emergency department setting.
Clinical Indication
The Sudbury Vertigo Risk Score is indicated for bedside clinical practice to support Identifies vertigo patients at higher risk for serious central diagnosis including stroke, TIA, vertebral artery dissection, or brain tumor in the emergency department setting.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.
Limitations & Contraindications
Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis. Clinical exclusion: Not applicable for patients with episodic vertigo lasting <24 hours.
Clinical Pearls & Action Plan
Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility. Guideline pearl: External validation showed 100% sensitivity and 69.2% specificity for score <5.
Score = Sum of points for: Male sex + Age >65 + Hypertension + Diabetes + Motor/sensory deficits + Cerebellar signs - BPPV diagnosis. Range: -4 to 17 points.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| male_sex | string | Yes | Patient is male |
| age_over_65 | string | Yes | Patient age is over 65 years |
| hypertension | string | Yes | History of hypertension |
| diabetes | string | Yes | History of diabetes mellitus |
| motor_sensory_deficits | string | Yes | Motor or sensory deficits on examination |
| cerebellar_signs | string | Yes | Cerebellar signs/symptoms (diplopia, dysarthria, dysphagia, dysmetria, ataxia) |
| bppv_diagnosis | string | Yes | Clinical diagnosis of benign paroxysmal positional vertigo (BPPV) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| -4–4 | Low Risk | 0% risk of serious diagnosis |
| 5–8 | Moderate Risk | 2.1% risk of serious diagnosis |
| 9–17 | High Risk | 41% risk of serious diagnosis |
Evidence-Based References (EBM)
- Lelli D, Dinh J, Ahuja N, et al. Development of a Clinical Risk Score to Risk Stratify for a Serious Cause of Vertigo in Patients Presenting to the Emergency Department. Ann Emerg Med. 2024 Nov;84(5):500-511. doi: 10.1016/j.annemergmed.2024.06.003.DOI: 10.1016/j.annemergmed.2024.06.003
- de Guise C, Chagnon M, Boudier-Revéret M, et al. Validation of the Sudbury Vertigo Risk Score to risk stratify for a serious cause of vertigo. Acad Emerg Med. 2024 Dec;31(12):1218-1227. doi: 10.1111/acem.14950.DOI: 10.1111/acem.14950
- Newman-Toker DE, Edlow JA. TiTrATE: A Novel, Evidence-Based Approach to Diagnosing Acute Dizziness and Vertigo. Neurol Clin. 2015 Aug;33(3):577-99. doi: 10.1016/j.ncl.2015.04.011.DOI: 10.1016/j.ncl.2015.04.011